AMED Amedisys Inc.

Amedisys to Present at the 2021 RBC Capital Markets Global Healthcare Conference

Amedisys to Present at the 2021 RBC Capital Markets Global Healthcare Conference

BATON ROUGE, La., May 10, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, Chairman and Chief Executive Officer, and Chris Gerard, President and Chief Operating Officer, will present at the 2021 RBC Capital Markets Healthcare Conference on Tuesday, May 18, 2021.

The presentation will begin at 1:20 p.m. Eastern Time. To access a live webcast of the Amedisys presentation, please log on through our website at .

About Amedisys:

Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,900 hospitals and 78,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, La. with an executive office in Nashville, Tenn., Amedisys is a publicly held company. With approximately 21,000 employees in 514 care centers in 39 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 418,000 patients and clients in need every year. For more information about the Company, please visit: .

Contact:

Amedisys, Inc.

Investor Relations

855.259.2046



EN
10/05/2021

Underlying

AMEDAmedisys Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Amedisys Inc.

 PRESS RELEASE
Free
AMED AMEDISYS INC.

Amedisys Reports First Quarter 2024 Financial Results

Amedisys Reports First Quarter 2024 Financial Results BATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2024. Three-Month Periods Ended March 31, 2024 and 2023 Net service revenue increased $15.0 million to $571.4 million compared to $556.4 million in 2023. Prior year included $15.0 million of net service revenue from our personal care business which was divested on March 31, 2023.Net income attributable to Amedisys, Inc. of $14.4 million, which is inclusive of merger-relat...

April 24, 2024 1 EN
 PRESS RELEASE
Free
AMED AMEDISYS INC.

Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results

Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results BATON ROUGE, La., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2023. Three-Month Periods Ended December 31, 2023 and 2022 Net service revenue increased $8.8 million to $570.8 million compared to $562.0 million in 2022. Prior year included $15.9 million of net service revenue from our personal care business which was divested on March 31, 2023.Net income attributable to Amedisys, Inc. of $19.3 million, which is...

February 21, 2024 1 EN
 PRESS RELEASE
Free
AMED AMEDISYS INC.

Amedisys Offers Molecular Testing for Rapid and Accurate Infection Dia...

Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis BATON ROUGE, La., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is now offering advanced molecular testing to its care centers nationwide. This innovative collaboration with Patient Choice Laboratories utilizes molecular testing for the swift and precise identification of pathogens in urine, respiratory and wound infections. By leveraging the latest in diagnostic technology, Amedisys aims to improve the quality of infe...

February 8, 2024 1 EN
 PRESS RELEASE
Free
AMED AMEDISYS INC.

Amedisys Reports Third Quarter 2023 Financial Results

Amedisys Reports Third Quarter 2023 Financial Results BATON ROUGE, La., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2023. Three-Month Periods Ended September 30, 2023 and 2022 Net service revenue decreased $1.8 million to $556.2 million compared to $558.0 million in 2022. Prior year included $16.6 million of net service revenue from our personal care business which was divested on March 31, 2023.Net income attributable to Amedisys, Inc. of $26.0 million compared to $25.6 mi...

October 24, 2023 1 EN
 PRESS RELEASE
Free
AMED AMEDISYS INC.

Amedisys Celebrates National Quality Week

Amedisys Celebrates National Quality Week Held October 15-21, this Observance Shines a Light on Our Commitment to Quality Care BATON ROUGE, La., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is proud to celebrate National Quality Week October 15-21, 2023. This week-long observance serves as an opportunity for Amedisys to recognize and highlight the organization's commitment to delivering the highest standard of quality care. During National Quality Week, Amedisys will focus on the importance...

October 18, 2023 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch